IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tybourne Capital Management HK LTD

Q2 2025 Holdings

Filed 2025-08-01 | 6 holdings | $34.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Forte Biosciences Inc (Fbrx US)(FBRX)COM NEW34962G208$10.2M786,64729.4%
Taysha Gene Therapies Inc (Tsha US)(TSHA)COM SHS877619106$9.5M4,095,00027.4%
Bicycle Therapeutics Ltd-ADR (Bcyc US)(BCYC)SPONSORED ADS088786108$6.9M993,74320.0%
Alumis Inc (Alms US)(ALMS)COM022307102$4.2M1,399,25012.2%
Malibu Boats Inc (Mbuu US)(MBUU)COM CL A56117J100$2.1M66,7056.1%
Zentalis Pharmaceuticals Inc (Zntl US)(ZNTL)COM98943L107$1.7M1,478,1525.0%